American Fertility Medical Center, Genetic Infertility & Andrology Lab

Warning LetterOpen

United StatesIssued Apr 2, 2020

Letter not published by FDA

Source: FDA warning letter records. FDA has not published the text of this letter.

Violations0

Issue DateApr 2, 2020

Product TypeBiologics

StatusOpen

Letter Details

Firm: American Fertility Medical Center, Genetic Infertility & Andrology Lab
Location: United States
FEI Number: N/A
Country: United States
Issue Date: April 02, 2020
Issuing Office: N/A
Product Type: Biologics
Status: Open

Summary

Based on limited metadata, this Warning Letter was issued to American Fertility Medical Center's Genetic Infertility & Andrology Lab on April 2, 2020, regarding biologics products or services. Without access to the full letter text or subject line details, the specific nature of the violations cannot be determined from the available information. The FDA's action indicates regulatory concerns related to biological products within the fertility and genetic testing sector, though the exact compliance issues and scope of violations remain unclear from this metadata alone.

American Fertility Medical Center, Genetic Infertility & Andrology Lab FDA Warning Letter, April 2, 2020